login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NEONC TECHNOLOGIES HOLDINGS (NTHI) Stock News
USA
- NASDAQ:NTHI -
US64051A1016
-
Common Stock
9.08
USD
+0.1 (+1.11%)
Last: 11/14/2025, 4:30:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NTHI Latest News, Press Relases and Analysis
All
Press Releases
4 hours ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
4 hours ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
a day ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
a day ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
3 days ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Reports Updated Clinical Results
7 days ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
7 days ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
10 days ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth
10 days ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth
18 days ago - By: NeOnc Technologies Holdings, Inc.
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
18 days ago - By: NeOnc Technologies Holdings, Inc.
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
a month ago - By: ACCESS Newswire
- Mentions:
SNYR
DVLT
ACXP
PETV
...
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
a month ago - By: ACCESS Newswire
- Mentions:
STSS
AERT
LASE
SNYR
...
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
a month ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
2 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
2 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
2 months ago - By: ACCESS Newswire
- Mentions:
STSS
AERT
LASE
SGTM
...
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
2 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT
2 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT
2 months ago - By: ACCESS Newswire
- Mentions:
STSS
LASE
TONX
ACXP
...
New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST
2 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
2 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
3 months ago - By: ACCESS Newswire
New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer
3 months ago - By: NeOnc Technologies Holdings, Inc.
NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer
Please enable JavaScript to continue using this application.